Immune-related dermatitis

Clinical trials for Immune-related dermatitis explained in plain language.

Never miss a new study

Get alerted when new Immune-related dermatitis trials appear

Sign up with your email to follow new studies for Immune-related dermatitis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Not yet finished but already full! 1

New foam aims to soothe immunotherapy skin side effects

Symptom relief Not yet recruiting

This phase 2 trial tests a medicated foam called roflumilast on skin rashes caused by checkpoint inhibitor cancer drugs. Twenty adults with mild to severe rash will apply the foam daily for 16 weeks. The goal is to see if it safely reduces rash severity and improves quality of li…

Matched conditions: IMMUNE-RELATED DERMATITIS

Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief

Last updated Jun 27, 2026 13:07 UTC

Immune-related dermatitis

Get alerted when new Immune-related dermatitis trials appear

New foam aims to soothe immunotherapy skin side effects